1. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Issue 10 (13th March 2020) Authors: Puduvalli, Vinay K; Wu, Jing; Yuan, Ying; Armstrong, Terri S; Vera, Elizabeth; Wu, Jimin; Xu, Jihong; Giglio, Pierre; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris D; Tran, David; Iwamoto, Fabio; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberla... Journal: Neuro-oncology Issue: Volume 22:Issue 10(2020) Page Start: 1505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma. (January 2017) Authors: Trusheim, John; Dunbar, Erin; Battiste, James; Iwamoto, Fabio; Mohile, Nimish; Damek, Denise; Bota, Daniela A; Connelly, Jennifer Journal: CNS oncology Issue: Volume 6:Number 1(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS. (5th November 2018) Authors: Puduvalli, Vinay; Wu, Jing; Yuan, Ying; Armstrong, Terri; Wu, Jimin; Giglio, Pierre; Xu, Jihong; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris; Iwamoto, Fabio; Tran, David; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberlain, Marc; Merrell, Ryan... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA. (11th November 2019) Authors: Arrillaga-Romany, Isabel; Kurz, Sylvia; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; DeGroot, John; Chi, Andrew; Sulman, Erik; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Iwamoto, Fabio; Leia Nghiemphu, P; Cloughesy, Timothy; Tarapore, Rohinton; Merdinger, Krystal; Os... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Issue 11 (6th November 2017) Authors: Bahng, Hye Hyun; Green, Stacey; Lai, Albert; Hu, Jethro; Green, Richard; Iwamoto, Fabio; Lassman, Andrew B; Cloughesy, Timothy; Nghiemphu, Phioanh Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. Issue 3 (26th October 2022) Authors: Brastianos, Priscilla K.; Twohy, Erin L.; Gerstner, Elizabeth R.; Kaufmann, Timothy J.; Iafrate, A. John; Lennerz, Jochen; Jeyapalan, Suriya; Piccioni, David E.; Monga, Varun; Fadul, Camilo E.; Schiff, David; Taylor, Jennie W.; Chowdhary, Sajeel A.; Bettegowda, Chetan; Ansstas, George; De La Fuen... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ATIM-08. TRIAL IN PROGRESS: CA209-9Y8 PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFS), NIVOLUMAB PLUS/MINUS IPILIMUMAB FOR BEVACIZUMAB-NAÏVE, RECURRENT GLIOBLASTOMA. (11th November 2019) Authors: Odia, Yazmin; Iwamoto, Fabio Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ATIM-14. CMV gB/pp65 eVLPs FORMULATED WITH GM-CSF AS A THERAPEUTIC VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM). (5th November 2018) Authors: Iwamoto, Fabio; Diaz-Mitoma, Francisco; Anderson, David; Lassman, Andrew B Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ATIM-23. ANTI-CD27 AGONIST ANTIBODY VARLILUMAB IN COMBINATION WITH NIVOLUMAB FOR RECURRENT GLIOBLASTOMA (rGBM): PHASE 2 CLINICAL TRIAL RESULTS. (5th November 2018) Authors: Reardon, David; Kaley, Thomas; Iwamoto, Fabio; Baehring, Joachim; Subramaniam, Deepa; Rawls, Tracey; He, Yi; Keler, Tibor; Yellin, Michael Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ATIM-26. INTERIM RESULTS OF THE EXTENSION PHASE OF A PHASE I/IIA TRIAL OF A THERAPEUTIC CMV VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Wen, Patrick; Reardon, David; Lee, Eudocia; Iwamoto, Fabio; Anderson, David; Diaz-Mitoma, Francisco; Lassman, Andrew Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗